Haloperidol for postoperative nausea and vomiting: Are we reinventing the wheel?

Anesthesia and Analgesia

Volumn 106, Issue 5, 2008, Pages 1343-1345

  Habib, Ashraf S ^a,b   Gan, Tong J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DROPERIDOL; HALOPERIDOL; ONDANSETRON; PLACEBO; ANTIEMETIC AGENT; GENERIC DRUG;

AKATHISIA; ANESTHESIOLOGICAL TECHNIQUES; ANTICHOLINERGIC EFFECT; COST EFFECTIVENESS ANALYSIS; DELIRIUM; DOSE RESPONSE; DRUG COST; DRUG HALF LIFE; DRUG SAFETY; ECONOMIC ASPECT; EDITORIAL; EXTRAPYRAMIDAL SYMPTOM; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HUMAN; NEUROLEPTIC MALIGNANT SYNDROME; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; QT PROLONGATION; SEDATION; SIDE EFFECT; TARDIVE DYSKINESIA; TORSADE DES POINTES; COST BENEFIT ANALYSIS; DRUG APPROVAL; DRUG COMBINATION; DRUG EFFECT; DRUG LABELING; ECONOMICS; EUROPE; HEART MUSCLE CONDUCTION SYSTEM; NOTE; UNITED STATES;

ANTIEMETICS; COST-BENEFIT ANALYSIS; DROPERIDOL; DRUG APPROVAL; DRUG COSTS; DRUG LABELING; DRUG THERAPY, COMBINATION; DRUGS, GENERIC; EUROPE; HALOPERIDOL; HEART CONDUCTION SYSTEM; HUMANS; ONDANSETRON; POSTOPERATIVE NAUSEA AND VOMITING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 42449098537     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31816a6aff     Document Type: Editorial

References (21)

1. White PF. Droperidol: a cost-effective antiemetic for over thirty years. Anesth Analg 2002;95:789-90
2. Habib AS, Gan TJ. Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003;96:1377-9
3. Gan TJ, White PF, Scuderi PE, Watcha MF, Kovac A. FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified? Anesthesiology 2002;97:287
4. Habib AS, Gan TJ. The use of droperidol before and after the FDA black box warning: a survey of the members of the Society of Ambulatory Anesthesia (SAMBA). J Clin Anesth 2008;20:35-9
5. Fortney JT, Gan TJ, Graczyk S, Wetchler B, Melson T, Khalil S, McKenzie R, Parrillo S, Glass PS, Moote C, Wermeling D, Parasuraman TV, Duncan B, Creed MR. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Anesth Analg 1998;86:731-8
6. Henzi I, Sonderegger J, Tramer MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anaesth 2000;47:537-51
7. Habib AS, El-Moalem HE, Gan TJ. The efficacy of the 5-HT(3) receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials. Can J Anaesth 2004;51:311-9
8. Gan TJ, Meyer TA, Apfel CC, Chung F, Davis PJ, Habib AS, Hooper VD, Kovac AL, Kranke P, Myles P, Philip BK, Samsa G, Sessler DI, Temo J, Tramer MR, Vander Kolk C, Watcha M. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007;105:1615-28
9. Sharma ND, Rosman HS, Padhi ID, Tisdale JE. Torsades de Pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998;81:238-40
10. Cheng YF, Paalzow LK, Bondesson U, Ekblom B, Eriksson K, Eriksson SO, Lindberg A, Lindstrom L. Pharmacokinetics of haloperidol in psychotic patients. Psychopharmacology (Berl) 1987;91:410-4
11. Hassaballa HA, Balk RA. Torsade de pointes associated with the administration of intravenous haloperidol: a review of the literature and practical guidelines for use. Expert Opin Drug Saf 2003;2:543-7
12. Metzger E, Friedman R. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. J Clin Psychopharmacol 1993;13:128-32
13. Buttner M, Walder B, von Elm E, Tramer MR. Is low-dose haloperidol a useful antiemetic?: a meta-analysis of published and unpublished randomized trials. Anesthesiology 2004;101:1454-63
14. Wang TF, Liu YH, Chu CC, Shieh JP, Tzeng JI, Wang JJ. Low-dose haloperidol prevents post-operative nausea and vomiting after ambulatory laparoscopic surgery. Acta Anaesthesiol Scand 2007;Epub ahead of print
15. Lee Y, Wang PK, Lai HY, Yang YL, Chu CC, Wang JJ. Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting. Can J Anaesth 2007;54:349-54
16. Aouad MT, Siddik-Sayyid SM, Taha SK, Azar MS, Nasr VG, Hakki MA, Zoorob DG, Baraka AS. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery. Eur J Anaesthesiol 2007;24:171-8
17. Grecu L, Bittner EA, Kher J, Smith SE, Rosow CE. Haloperidol plus ondansetron versus ondansetron alone for prophylaxis of postoperative nausea and vomiting. Anesth Analg 2008;106:1410-3
18. Rosow CE, Haspel KL, Smith SE, Grecu L, Bittner EA. Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting. Anesth Analg 2008;106:1407-9
19. Chu CC, Shieh JP, Tzeng JI, Chen JY, Lee Y, Ho ST, Wang JJ. The prophylactic effect of haloperidol plus dexamethasone on postoperative nausea and vomiting in patients undergoing laparoscopically assisted vaginal hysterectomy. Anesth Analg 2008;106:1402-6
20. Fischler M, Bonnet F, Trang H, Jacob L, Levron JC, Flaisler B, Vourc'h G. The pharmacokinetics of droperidol in anesthetized patients. Anesthesiology 1986;64:486-9
21. Available at: http://www.fda.gov/CDER/Drug/InfoSheets/HCP/haloperidol. htm. Accessed December 14, 2007